Global Botanical Supplement and Drug Market Growth (Status and Outlook) 2023-2029
The global Botanical Supplement and Drug market size is projected to grow from US$ 18830 million in 2022 to US$ 30550 million in 2029; it is expected to grow at a CAGR of 7.2% from 2023 to 2029.
United States market for Botanical Supplement and Drug is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Botanical Supplement and Drug is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Botanical Supplement and Drug is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Botanical Supplement and Drug players cover Buchang Pharmaceuticals, China TCM, Tsumura, Schwabe, Tong Ren Tang, Jumpcan Pharmaceutical, Guangzhou Baiyunshan Pharmaceutical, Yunnan Baiyao and Tasly Holding Group, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
Botanical dietary supplements, sometimes called herbals or herbal dietary supplements, are products made from plants, plant parts, or plant extracts. They are meant to be consumed and contain one or more ingredients meant to supplement the diet.
LPI (LP Information)' newest research report, the “Botanical Supplement and Drug Industry Forecast” looks at past sales and reviews total world Botanical Supplement and Drug sales in 2022, providing a comprehensive analysis by region and market sector of projected Botanical Supplement and Drug sales for 2023 through 2029. With Botanical Supplement and Drug sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Botanical Supplement and Drug industry.
This Insight Report provides a comprehensive analysis of the global Botanical Supplement and Drug landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Botanical Supplement and Drug portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Botanical Supplement and Drug market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Botanical Supplement and Drug and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Botanical Supplement and Drug.
This report presents a comprehensive overview, market shares, and growth opportunities of Botanical Supplement and Drug market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Drugs
Food and Beverages
Cosmetics
Segmentation by application
Hospital
Retail Pharmacy
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Buchang Pharmaceuticals
China TCM
Tsumura
Schwabe
Tong Ren Tang
Jumpcan Pharmaceutical
Guangzhou Baiyunshan Pharmaceutical
Yunnan Baiyao
Tasly Holding Group
Bionorica Se
Huarun 999
Taiji
Weleda
Kwangdong
GW Pharmaceuticals
Please note: The report will take approximately 2 business days to prepare and deliver.